Introduction
Cardiac ryanodine receptors (RyR2 channels) are intracellular ion channels in the membrane of the sarcoplasmic reticulum (SR) that provide a pathway for release of calcium ions from the SR into the cytosol. They are made up of four identical monomers, each consisting of approximately 5,000 amino acids. The large N-terminal cytoplasmic part of the RyR2 comprised of the N-terminal 80-90% of amino acids contains a multitude of regulatory ligand-binding and phosphorylation sites [1] . The transmembrane region, comprised of the remaining C-terminal 10-20% of amino acids, is responsible for the channel function of the protein [2] .
Mutations of RyR2 channels are responsible for the genetic diseases CVPT (catecholaminergic polymorphic ventricular tachycardia) and ARVD2 (arrhythmogenic right ventricular dysplasia) that lead to life-threatening arrhythmias, and have been found in cases of idiopathic ventricular fibrillation, syncope of unknown origin and sudden cardiac death associated with drowning (http://www.fsm.it/cardmoc/). These mutations alter the activity of the RyR2 channel and may result in premature calcium release in the absence of the action potential [1, 3] . Similar mutations in the skeletal muscle isoform of the RyR lead to malignant hyperthermia and central core disease [4] . The clustering of mutations into several regions of high occurrence led to the hypothesis that domains containing disease-causing mutations are involved in inter-domain interactions within the ryanodine receptor that keep the channel closed, and that these mutations result in defective inter-domain interaction ("domain unzipping") that leads to increased resting open probability [5] . Inter-domain interaction was proposed to be competitively inhibited by peptides from the interacting domains [1, 5] . Indeed, it has been shown that in agreement with this hypothesis the domain peptide from the central domain, DPc10 (RyR2  2460-2495 ), increased the open probability of the RyR by increasing mainly the sensitivity of RyR2 to activation by luminal calcium [6] . In this paper we have studied the effect of a novel peptide, DP CPVTc (RyR2 2380-2411 ), from the CPVT-causing central domain. The sequence encompassed by the peptide has been shown to harbor CPVT/ARVD2 mutations of eight different amino acids (http://www.fsm.it/cardmoc/). We report that DP CPVTc activates the ryanodine receptor by increasing both, the fraction of time that RyR2 spends in a high open probability mode and RyR2 open time within this mode.
Experimental Procedures

Chemicals
(DOPC), 1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPPC), and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were from Avanti Polar Lipids (USA).
The peptide DP CPVTc , containing amino acids 2380-2411 of the human RYR2 with the sequence 2380 DTIHMGNAIMTFYSALIDLLGRCAPEMHLIHA 2411 was synthesized by GenScript (USA). Aliquots of a 1 mmol L -1 stock solution of the lyophilized peptide in the cis solution were kept at -20°C. Increasing concentrations of DP CPVTc in the cis compartment were obtained by sequential additions of the stock solution.
Preparation of SR membrane vesicles
The rats were anesthetized with sodium pentobarbital (50 mg kg -1 i.p.). Excision of the myocardium was performed according to a procedure approved by the State veterinary and food administration of the Slovak Republic (Ro-3820/05-221, Ro-2821/09-221) and by the Ethical Committee of the Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences. Cardiac SR microsomes were isolated from rat heart ventricles and septum by differential centrifugation as previously described [7] , and 10 -15 µL aliquots were snap frozen in liquid nitrogen and stored at -70°C.
Single RYR2 channel measurements
Bilayer lipid membranes were formed over a 20 -50 µm aperture in a polystyrene chamber. The aperture was first treated with a solution (26 mg mL -1 ) of 1,2-dioleoyl-snglycero-3-phospho-L-serine (DOPS), 1,2-dioleoyl-snglycero-3-phosphocholine (DOPC) and 1,2-diphytanoylsn-glycero-3-phosphocholine (DPPC) in a 3:5:5 ratio in n-decane (Aldrich, USA). After evaporation of n-decane, the cis and trans compartments of the bilayer chamber were filled with the solutions (in mmol L 2 , pH 7.35 and a bilayer was formed using a mixture of DOPS and DOPE (3:10; 26 mg mL -1 in n-decane). After formation of a bilayer, RYR2 channels were incorporated from a suspension of microsomal vesicles of the SR, added to the cis compartment. The volume of the cis solution was kept at 1.0 mL.
Currents through the incorporated single RYR2 channels were measured in voltage-clamp mode at a holding potential of 0 mV with MultiClamp 700B amplifier (Axon Instruments, Union City, CA, USA) with a 50 GΩ feedback resistor. The signal was filtered by a 4-pole Bessel filter at 1 kHz and digitized using an A/D converter (Digidata 1440A, Axon Instruments, Union City, CA, USA) at a frequency of 4 kHz. Acquisition and analysis were performed using pClamp software (Ver. 10, Axon Instruments, Burlingame, CA, USA). Statistical analysis was performed in the program Origin (Ver. 8.0 SR6, OriginLab Corporation, Northampton, USA).
Other chemicals were from Sigma-Aldrich (USA).
Results
The identity of the observed channels as the Ca
2+
release channels of the SR cisternae was confirmed by their activation by micromolar [Ca 2+ ] and by ATP from the cytoplasmic side, and by their inhibition by millimolar concentrations of Mg 2+ from the cytoplasmic side [8, 9] . Measurements were performed at a cytosolic Ca 2+ concentration of 100 nmol L -1 to mimic diastolic conditions, under which the detrimental effect of RyR2 mutations occurs in vivo [1, 3] . Luminal Ca 2+ was increased to 8 mmol L -1 to eliminate a possible effect of the peptide via Ca 2+ feed-through [6, 9] . Typical current traces of a single RyR2 channel under diastolic conditions at various concentrations of added DP CPVTc are illustrated in Figure 1A . At a holding potential of 0 mV, RyR2 channels had a very low open probability at 100 nmol L -1 cis Ca 2+ ( Figure 1A , top trace). Individual openings (mean open time, t O = 10.0 ± 3.9 ms) occurred rarely (t C = 8.6 ± 2.3 s), accounting for the open probability of 0.0017 ± 0.0005 in the absence of DP CPVTc . Addition of DP CPVTc to the cis compartment induced an increase in channel activity that was quite substantial at 20 µmol L luminal Ca 2+ ) and those of the RyR channel activated by cytosolic Ca 2+ at 53 mmol L -1 luminal Ca 2+ [7] are shown in Figure 2A , B for comparison as solid and dashed lines, respectively. There is a prominent difference between the effect of DP CPVTc and either ATP or cytosolic Ca 2+ : the effect of the peptide on channel open times is much stronger, while its effect on closed times is much weaker than that of ATP or cytosolic Ca 2+ . It has to be noted that under the conditions of the present experiments, ATP is able to induce much stronger activation of the channel [9] .
We have noticed that at all DP CPVTc concentrations there was a minimum in the frequency of occurrence of records with P O between 0.001-0.004 (data not shown). Therefore we tested the possibility that the variability of RyR activity ( Figure 1A-C) is due to the presence of two gating modes with a different open probability [10] . [9] , and by cytosolic Ca 2+ at a luminal calcium concentration of 53 mmol L -1 [7] . Individual 10-s records were assigned to the low-or high-open probability (L-or H-) mode using a critical open probability P crit = 0.003. The gating parameters of the low-P O records were independent of DP CPVTc concentration (Figure 3) , while the open probability and open time of the high-P O records concentrationdependently increased with [DP CPVTc ] (Figure 3A,B) . The closed time duration did not depend on [DP CPVTc ] (Figure 3C ), while the fraction of segments displaying high open probability ( Figure 3D) 
Discussion
The investigated peptide DP CPVTc , 2380 DTIHMGNAIMTFYSALIDLLGRCAPEMHLIHA 2411 , has eight amino acids, in which a total of 10 diseaseassociated mutations or coding single nucleotide polymorphisms (cSNPs) have been documented (shown in bold; N2386I [11] , A2387T [12] , A2387P [13] , M2389L [14] , Y2392C [15] , A2394G [16] , R2401H [17] , R2401L [18] , A2403T [12, 19] , and P2404T [14, 20] ). These mutations/cSNPs are associated with ARVD (N2386I, Y2392C), CPVT (A2387P, A7165C, A2394G, R2401H, R2404T), syncope of unknown origin (A2387T, A2403T), sudden cardiac death (A2403T) and exerciseinduces idiopathic ventricular fibrillation (R2401L). DP CPVTc corresponds to a RyR2 sequence located between two parts of the central domain of the RyR that are hypothesized to differ in their mechanism of RyR regulation. DP CPVTc lies N-terminally to the part of the central domain hypothesized to physically interact with the N-terminal domain [21] and containing the cardiac equivalent of the sequence of the peptide DP4 [22] and the sequence of the peptide DPc10 [23] . Mutations in this region are supposed to weaken the interaction of the central domain with the N-terminal domain [22, 23] . The DP4 peptide from the RyR1 isoform has been shown to affect both skeletal and cardiac RyR channels and Table 2 for details). Please note the logarithmic scale of the Y-axis in panel A. to increase calcium release [22] . The peptide DPc10 (aa 2,460-2,495) has been shown to activate calcium release and ryanodine binding in RyR2 channels [23] and to increase RyR2 P O by increasing the sensitivity to luminal calcium [6] . DP CPVTc is located within the region spanned by the peptide DP8 in the skeletal RyR1 isoform [24] , the effect of which has not been studied. DP CPVTc is located C-terminally to the part of the central domain (amino acids 2,232-2,266) hypothesized to physically interact with the K201-biding domain (amino acids 2,114-2,149, [25] ). Mutations in this region are supposed to strengthen the interaction with the K201-binding domain [26] . If the mode of action of DP CPVTc paralleled that of DP2246, binding would not be supposed to induce unzipping of the domain switch; moreover, the position of DP CPVTc in the RyR sequence is much closer to DPc10 than to DP2246. Therefore, we assume that the mode of action of DP CPVTc similar to that of DPc10, i.e., it includes a direct effect on the domain switch. The presence of a large number of mutation sites in DP CPVTc prevented us from designing a mutant "sham" peptide that should lack effects on the ryanodine receptor (introduction of several mutations at once would most likely lead to a change in the secondary structure of the peptide); however, this inconvenience was compensated by the large amplitude of the observed effects. The effects of DP CPVTc on RyR2 open probability, open time and reciprocal closed time were concentrationdependent and followed the Hill function for all studied single channels. This suggests that changing ligand concentration changes the fractional occupancy of individual binding sites (fraction of time the site is bound to the peptide). Since RyR2 is a homotetramer, the existence of four equivalent binding sites can be assumed. At the same time, concentration dependence of RyR2 gating parameters is a strong indication that the interaction between the channel and DP CPVTc is readily reversible; otherwise an all-or-none effect should be observed, as, e.g., for the effect of DIDS on RyR2 activity [27] .
At saturating concentrations, the effect of DPc10 on open probability and open and closed times was much smaller than the respective effect of ATP [6] . Our data show that the effect of the peptides DP CPVTc on open probability and on closed time is smaller than the effect of ATP [9] , as is the case with DPc10 [6] . In contrast to DPc10, DP CPVTc induces a much larger effect on open times, when compared with ATP. Since the peptide DPc10 slightly increased RyR sensitivity to cytosolic Ca 2+ [6, 23] , and RyR activation was dependent on luminal Ca 2+ [6] , the effect of DPc10 has been attributed to Ca 2+ feed-through and explained as the consequence of perturbation of channel gating associated with the calcium activation (A-) site [6] . In the case of our experiments the effect of DP CPVTc could not have been mediated by Ca 2+ feed-through, which has been shown to be saturated at 8 mmol L -1 luminal Ca 2+ [9] . It is unlikely that the effect of the peptide could have been caused by direct modulation of either the A-site [6] or the L A -site [9] , since cytosolic Ca 2+ and 53 mmol L -1 luminal Ca 2+ [7] increase open time much less that DP CPVTc does.
A large variation of open probability, open time and frequency of openings at a constant DP CPVTc concentration could be observed, when these parameters were averaged over 10-s intervals. This variation was observed in all channels at all peptide concentrations, and therefore could not be ascribed to channel heterogeneity. The variation could be explained by spontaneous transitions of the RyR2 channel between H-and L-gating modes [10] that differ in their response to DP CPVTc .
RyR open probability as well as open probability within the H-mode remained relatively low even at saturating peptide concentrations, and therefore the long channel openings cannot be indications of the peptide-binding events. Moreover, the probability of H-mode occurrence did not reach the value of one at saturating [DP CPVTc ]. The persistence of L-mode gating at saturating [DP CPVTc ] indicates that this ligand can bind to the channel in either mode of activity but that the allosteric interaction with the channel-opening transition (i.e. the allosteric coupling between "domain unzipping" and channel opening) occurs only in the H-mode.
On the basis of these results we propose that binding of DP CPVTc displaces the homologous sequence of the channel from its binding site, causing unzipping of the "domain switch". This transition modulates RyR gating in two ways. First, it decreases the probability of the L-mode of activity. Second, it slows down the transitions from the H-mode open state(s) into closed states, as documented by the prolongation of H-mode open time. Since the channel is allosterically regulated also by cytosolic Ca 2+ [28] [29] [30] [31] , luminal Ca 2+ [9] , and ATP [9] , it is likely that binding of the peptide will affect interaction of RyR2 with all these ligands. 
